Press Releases Year None2023202220212020201920182017 Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome December 26, 2023 PDF Version READ MORE Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives November 14, 2023 PDF Version READ MORE Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross September 21, 2023 PDF Version READ MORE Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring August 10, 2023 PDF Version READ MORE Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting June 5, 2023 PDF Version READ MORE Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments May 10, 2023 PDF Version READ MORE Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting April 26, 2023 PDF Version READ MORE Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference April 13, 2023 PDF Version READ MORE Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update March 29, 2023 PDF Version READ MORE Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023 March 23, 2023 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
